project id: TCGA-STAD; case submitter id: TCGA-3M-AB46; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.8; age at index: 70; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1939; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1765.0; icd 10 code: C16.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lesser curvature of stomach, NOS; synchronous malignancy: No; tissue or organ of origin: Lesser curvature of stomach, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1507; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-3M-AB46-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0;